By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...
But new research may have found the key to answering the mysterious increase in colorectal cancer cases in young people — and ...
Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...
Bowel cancer rates have been rising in people under 55 for years. But scientists have yet to determine the reason.
A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...
Many Americans aren't getting enough fiber, while colorectal cancer rates are increasing in younger adults. Is fibermaxxing ...
Weight loss and diabetes drugs such as Ozempic and Wegovy may help reduce colon cancer risk, a new study presented at the ...
A college athlete had stabbing stomach pains that wouldn't go away for months.After several days of tests, doctors discovered ...
Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.
Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...
Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results